A-1210477
CAS1668553-26-1
⚠ This product is for research use only, not for human or veterinary use.
We typically respond within 1 business day.
| CAS Number | 1231929-97-7 |
| IUPAC Name | N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine |
| Synonyms | Verzenio; Verzenios; LY2835219; N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine |
| Molecular Weight | 506.60 g/mol |
| Molecular Formula | C27H32F2N8 |
| PubChem CID | 46220502 |
| SMILES | CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F |
| Purity | >98% |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
Abemaciclib (CAS 1231929-97-7) is a selective, orally bioavailable cyclin-dependent kinase (CDK) inhibitor with molecular formula C₂₇H₃₂F₂N₈ and MW 506.60 g/mol. It is also known as LY2835219 and Verzenio.
Abemaciclib is reported to act as a potent, ATP-competitive inhibitor of CDK4 and CDK6, kinases that phosphorylate the retinoblastoma protein (Rb) to drive G1-to-S phase cell cycle progression. By blocking Rb phosphorylation, it is reported to arrest susceptible cells in G1 and suppress proliferation. Its benzimidazole-pyrimidine scaffold confers selectivity within the CDK family, with notably continuous dosing tolerance relative to other CDK4/6 inhibitors.
Each batch is analyzed by HPLC and ¹H NMR, with a Certificate of Analysis provided on shipment. Available from milligram to kilogram scale, with flexible packaging to meet R&D and scale-up requirements.
All analytical documentation is provided free of charge with every order. Raw spectral data files (NMR, HPLC, LC-MS) are also available on request — just mention it in your enquiry.